Flavan-3-ols, anthocyanins, and inflammation

IUBMB Life

Volumn 66, Issue 11, 2014, Pages 745-758

  Mena, Pedro ^a   Domínguez Perles, Raúl ^b   Gironés Vilaplana, Amadeo ^c   Baenas, Nieves ^c   García Viguera, Cristina ^c   Villaño, Débora ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

anthocyanins; atherosclerosis; bioavailability; biomarkers; diabetes; dyslipemia; flavan 3 ols; inflammation; metabolic syndrome; plant foods

Indexed keywords

ANTHOCYANIN; ANTIINFLAMMATORY AGENT; FLAVAN 3 OL DERIVATIVE; FLAVANOL DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; FLAVAN-3-OL; FLAVONOID;

ANTIINFLAMMATORY ACTIVITY; DRUG BIOAVAILABILITY; ENZYME ACTIVATION; HUMAN; IN VITRO STUDY; INFLAMMATION; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN; DIET THERAPY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYTOTHERAPY; PROCEDURES; TRENDS;

ANIMALIA;

ANTHOCYANINS; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; INFLAMMATION; NF-KAPPA B; PHYTOTHERAPY; SIGNAL TRANSDUCTION;

EID: 84920864609     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1332     Document Type: Review

References (115)

1. Hall, J. E., and, Guyton, A. C., (2011) Guyton and Hall Textbook of Medical Physiology. Saunders/Elsevier, Philadelphia.
2. Lind, D. S., Hochwald, S. N., Malaty, J., Rekkas, S., Hebig, P., et al. (2001) Nuclear factor-κB is upregulated in colorectal cancer. Surgery 130, 363-369.
3. Weber, C., and, Noels, H., (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410-1422.
4. Detopoulou, P., Panagiotakos, D. B., Chrysohoou, C., Fragopoulou, E., Nomikos, T., et al. (2010) Dietary antioxidant capacity and concentration of adiponectin in apparently healthy adults: the ATTICA study. Eur. J. Clin. Nutr. 64, 161-168.
5. Gregor, M. F., and, Hotamisligil, G. S., (2011) Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445.
6. Holt, E. M., Steffen, L. M., Moran, A., Basu, S., Steinberger, J., et al. (2009) Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J. Am. Diet. Assoc. 109, 414-421.
7. Siri-Tarino, P. W., Sun, Q., Hu, F. B., and, Krauss, R. M., (2010) Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr. Atheroscler. Rep. 12, 384-390.
8. Cassidy, A., O'Reilly, E. J., Kay, C., Sampson, L., Franz, M., et al. (2011) Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 93, 338-347.
9. Cutler, G. J., Nettleton, J. A., Ross, J. A., Harnack, L. J., Jacobs, D. R. Jr., (2008) Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int. J. Cancer 123, 664-671.
10. McCullough, M. L., Peterson, J. J., Patel, R., Jacques, P. F., Shah, R., et al. (2012) Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am. J. Clin. Nutr. 95, 454-464.
11. Wedick, N. M., Pan, A., Cassidy, A., Rimm, E. B., Sampson, L., et al. (2012) Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr. 95, 925-933.
12. Arts, I. C., and, Hollman, P. C., (2005) Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81, 317S-325S.
13. Chuang, C. C., and, McIntosh, M. K., (2011) Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases, pp. 155-176.
14. de Pascual-Teresa, S., Moreno, D. A., and, Garcia-Viguera, C., (2010) Flavanols and anthocyanins in cardiovascular health: a review of current evidence. Int. J. Mol. Sci. 11, 1679-1703.
15. Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P., Tognolini, M., Borges, G., et al. (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 18, 1818-1892.
16. Joseph, S. V., Edirisinghe, I., and, Burton-Freeman, B. M.,. (2014) Berries: anti-inflammatory effects in humans. J. Agric. Food Chem. 62, 3886-3903.
17. Rodriguez-Mateos, A., Vauzour, D., Krueger, C. G., Shanmuganayagam, D., Reed, J., et al. (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch. Toxicol. 88, 1803-1853.
18. Knaze, V., Zamora-Ros, R., Lujan-Barroso, L., Romieu, I., Scalbert, A., et al. (2012) Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br. J. Nutr. 108, 1095-1108.
19. Aron, P. M., and, Kennedy, J. A., (2008) Flavan-3-ols: nature, occurrence and biological activity. Mol. Nutr. Food Res. 52, 79-104.
20. Crozier, A., Jaganath, I. B., and, Clifford, M. N., (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep. 26, 1001-1043.
21. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R., Garrido, I., et al. (2010) Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 1, 233-253.
22. Bittner, K., Rzeppa, S., and, Humpf, H. U., (2013) Distribution and quantification of flavan-3-ols and procyanidins with low degree of polymerization in nuts, cereals, and legumes. J. Agric. Food Chem. 61, 9148-9154.
23. Yang, Y. J., Kim, Y. J., Yang, Y. K., Kim, J. Y., and, Kwon, O., (2012) Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults. Nutr. Res. Pract. 6, 68-77.
24. de Pascual-Teresa, S., Santos-Buelga, C., and, Rivas-Gonzalo, J. C., (2000) Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J. Agric. Food Chem. 48, 5331-5337.
25. Vogiatzoglou, A., Mulligan, A. A., Luben, R. N., Lentjes, M. A., Heiss, C., et al. (2014) Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br. J. Nutr. 111, 1463-1473.
26. Clifford, M. N., van der Hooft, J. J., and, Crozier, A., (2013) Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am. J. Clin. Nutr. 98, 1619S-1630S.
27. Jaakola, L., (2013) New insights into the regulation of anthocyanin biosynthesis in fruits. Trends Plant Sci. 18, 477-483.
28. Fang, J., (2014). Some anthocyanins could be efficiently absorbed across the gastrointestinal mucosa: extensive presystemic metabolism reduces apparent bioavailability. J. Agric. Food Chem. 62, 3904-3911.
29. McGhie, T. K., Ainge, G. D., Barnett, L. E., Cooney, J. M., and, Jensen, D. J., (2003) Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J. Agric. Food Chem. 51, 4539-4548.
30. Prior, R. L., and, Wu, X., (2006) Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic. Res. 40, 1014-1028.
31. Mullen, W., Edwards, C. A., Serafini, M., and, Crozier, A., (2008) Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream. J. Agric. Food Chem. 56, 713-719.
32. Czank, C., Cassidy, A., Zhang, Q., Morrison, D. J., Preston, T., et al. (2013) Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: A 13C-tracer study. Am. J. Clin. Nutr. 97, 995-1003.
33. de Ferrars, R. M., Czank, C., Zhang, Q., Botting, N. P., Kroon, P. A., et al. (2014) The pharmacokinetics of anthocyanins and their metabolites in humans. Br. J. Pharmacol. 171, 3268-3282.
34. Correia, H., Gonzalez-Paramas, A., Amaral, M. T., Santos-Buelga, C., and, Batista, M. T., (2006) Polyphenolic profile characterization of Agrimonia eupatoria L. by HPLC with different detection devices. Biomed. Chromatogr. 20, 88-94.
35. Fraga, C. G., and, Oteiza, P. I., (2011) Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 51, 813-823.
36. Mackenzie, G. G., Adamo, A. M., Decker, N. P., and, Oteiza, P. I., (2008) Dimeric procyanidin B2 inhibits constitutively active NF-κB in Hodgkin's lymphoma cells independently of the presence of IκB mutations. Biochem. Pharmacol. 75, 1461-1471.
37. Mackenzie, G. G., Delfino, J. M., Keen, C. L., Fraga, C. G., and, Oteiza, P. I., (2009) Dimeric procyanidins are inhibitors of NF-κB-DNA binding. Biochem. Pharmacol. 78, 1252-1262.
38. Chitu, V., and, Stanley, E. R., (2006) Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18, 39-48.
39. Teitelbaum, S. L., (2006) Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8, 201.
40. Seo, S. W., Lee, D., Minematsu, H., Kim, A. D., Shin, M., et al. (2010) Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis. Bone 46, 695-702.
41. Lee, J. S., Kang, S. U., Hwang, H. S., Pyun, J. H., Choung, Y. H., et al. (2010) Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Toxicol. Lett. 199, 308-316.
42. Schroeter, H., Bahia, P., Spencer, J. P., Sheppard, O., Rattray, M., et al. (2007) (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J. Neurochem. 101, 1596-1606.
43. Erlejman, A. G., Jaggers, G., Fraga, C. G., and, Oteiza, P. I., (2008) TNFα-induced NF-κB activation and cell oxidant production are modulated by hexameric procyanidins in Caco-2 cells. Arch. Biochem. Biophys. 476, 186-195.
44. Patel, H. H., and, Insel, P. A., (2009) Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid. Redox Signal. 11, 1357-1372.
45. Fujimura, Y., Umeda, D., Yamada, K., and, Tachibana, H., (2008) The impact of the 67kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins. Arch. Biochem. Biophys. 476, 133-138.
46. Rosenwasser, L. J., (2011) Mechanisms of IgE inflammation. Curr. Allergy Asthma Rep. 11, 178-183.
47. Gu, Y., and, Lambert, J. D., (2013) Modulation of metabolic syndrome-related inflammation by cocoa. Mol. Nutr. Food Res. 57, 948-961.
48. Stote, K. S., Clevidence, B. A., Novotny, J. A., Henderson, T., Radecki, S. V., et al. (2012) Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance. Eur. J. Clin. Nutr. 66, 1153-1159.
49. Terra, X., Montagut, G., Bustos, M., Llopiz, N., Ardevol, A., et al. (2009) Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J. Nutr. Biochem. 20, 210-218.
50. García-Conesa, M. T., Tribolo, S., Guyot, S., Tomas-Barberan, F. A., and, Kroon, P. A., (2009) Oligomeric procyanidins inhibit cell migration and modulate the expression of migration and proliferation associated genes in human umbilical vascular endothelial cells. Mol. Nutr. Food Res. 53, 266-276.
51. Ford, A. C., Sandborn, W. J., Khan, K. J., Hanauer, S. B., Talley, N. J., et al. (2011) Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am. J. Gastroenterol. 106, 644-659, quiz 660.
52. Askling, J., Fahrbach, K., Nordstrom, B., Ross, S., Schmid, C. H., et al. (2011) Cancer risk with tumor necrosis factor α (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol. Drug Saf. 20, 119-130.
53. Cottone, M., Kohn, A., Daperno, M., Armuzzi, A., Guidi, L., et al. (2011) Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 9, 30-35.
54. Lauren, D. R., Smith, W. A., Adaim, A., Cooney, J. M., Wibisono, R., et al. (2009) Chemical composition and in vitro anti-inflammatory activity of apple phenolic extracts and of their sub-fractions. Int. J. Food Sci. Nutr. 60 (Suppl 7), 188-205.
55. Manach, C., Williamson, G., Morand, C., Scalbert, A., and, Remesy, C., (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81, 230S-242S.
56. Tsang, C., Auger, C., Mullen, W., Bornet, A., Rouanet, J. M., et al. (2005) The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br. J. Nutr. 94, 170-181.
57. Mackenzie, G. G., Carrasquedo, F., Delfino, J. M., Keen, C. L., Fraga, C. G., et al. (2004) Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-κB activation at multiple steps in Jurkat T cells. FASEB J. 18, 167-169.
58. Nielsen, H. V., Christensen, J. P., Andersson, E. C., Marker, O., and, Thomsen, A. R., (1994) Expression of type 3 complement receptor on activated CD8+ T cells facilitates homing to inflammatory sites. J. Immunol. 153, 2021-2028.
59. Kawai, K., Tsuno, N. H., Kitayama, J., Okaji, Y., Yazawa, K., et al. (2004) Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b. J. Allergy Clin. Immunol. 113, 1211-1217.
60. Monagas, M., Khan, N., Andres-Lacueva, C., Casas, R., Urpi-Sarda, M., et al. (2009) Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am. J. Clin. Nutr. 90, 1144-1150.
61. Farouque, H. M., Leung, M., Hope, S. A., Baldi, M., Schechter, C., et al. (2006) Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin. Sci. (Lond.) 111, 71-80.
62. Mathur, S., Devaraj, S., Grundy, S. M., and, Jialal, I., (2002) Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J. Nutr. 132, 3663-3667.
63. Lin, Y. L., and, Lin, J. K., (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 52, 465-472.
64. Lin, Y. L., Tsai, S. H., Lin-Shiau, S. Y., Ho, C. T., and, Lin, J. K., (1999) Theaflavin-3,3′-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-κB in macrophages. Eur. J. Pharmacol. 367, 379-388.
65. Andujar, I., Recio, M. C., Giner, R. M., Cienfuegos-Jovellanos, E., Laghi, S., et al. (2011) Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells. J. Agric. Food Chem. 59, 6474-6483.
66. Vazquez-Prieto, M. A., Bettaieb, A., Haj, F. G., Fraga, C. G., and, Oteiza, P. I., (2012) (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 527, 113-118.
67. Mizushina, Y., Saito, A., Tanaka, A., Nakajima, N., Kuriyama, I., et al. (2005) Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors. Biochem. Biophys. Res. Commun. 333, 101-109.
68. Arts, I. C., Jacobs, D. R., Jr., Harnack, L. J., Gross, M., and, Folsom, A. R., (2001) Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology 12, 668-675.
69. Loke, W. M., Proudfoot, J. M., Hodgson, J. M., McKinley, A. J., Hime, N., et al. (2010) Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 30, 749-757.
70. Noll, C., Lameth, J., Paul, J. L., and, Janel, N., (2013) Effect of catechin/epicatechin dietary intake on endothelial dysfunction biomarkers and proinflammatory cytokines in aorta of hyperhomocysteinemic mice. Eur. J. Nutr. 52, 1243-1250.
71. Morrison, M., van der Heijden, R., Heeringa, P., Kaijzel, E., Verschuren, L., et al. (2014) Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis 233, 149-156.
72. Al-Hanbali, M., Ali, D., Bustami, M., Abdel-Malek, S., Al-Hanbali, R., et al. (2009) Epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-κB nuclear translocation in whole blood stimulated system. Neuro Endocrinol. Lett. 30, 131-138.
73. Granado-Serrano, A. B., Martin, M. A., Haegeman, G., Goya, L., Bravo, L., et al. (2010) Epicatechin induces NF-κB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells. Br. J. Nutr. 103, 168-179.
74. Lyons, M. A., and, Wittenburg, H., (2006) Susceptibility to cholesterol gallstone formation: evidence that LITH genes also encode immune-related factors. Biochim. Biophys. Acta 1761, 1133-1147.
75. Koninger, J., di Mola, F. F., Di Sebastiano, P., Gardini, A., Brigstock, D. R., et al. (2005) Transforming growth factor-beta pathway is activated in cholecystolithiasis. Langenbecks Arch. Surg. 390, 21-28.
76. Shan, D., Fang, Y., Ye, Y., and, Liu, J., (2008) EGCG reducing the susceptibility to cholesterol gallstone formation through the regulation of inflammation. Biomed. Pharmacother. 62, 677-683.
77. Devore, E. E., Kang, J. H., Breteler, M. M., and, Grodstein, F., (2012) Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann. Neurol. 72, 135-143.
78. Cassidy, A., Mukamal, K. J., Liu, L., Franz, M., Eliassen, A. H., et al. (2013) High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 127, 188-196.
79. Jennings, A., Welch, A. A., Spector, T., Macgregor, A., and, Cassidy, A., (2014) Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J. Nutr. 144, 202-208.
80. Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., et al. (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122, e584-e636.
81. Herder, C., Karakas, M., and, Koenig, W., (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin. Pharmacol. Ther. 90, 52-66.
82. Hajer, G. R., Van Haeften, T. W., and, Visseren, F. L. J., (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 29, 2959-2971.
83. Kuntz, S., Kunz, C., Herrmann, J., Borsch, C. H., Abel, G., et al. (2014) Anthocyanins from fruit juices improve the antioxidant status of healthy young female volunteers without affecting anti-inflammatory parameters: results from the randomised, double-blind, placebo-controlled, cross-over ANTHONIA (ANTHOcyanins in Nutrition Investigation Alliance) study. Br. J. Nutr. 112, 925-936.
84. Lynn, A., Mathew, S., Moore, C. T., Russell, J., Robinson, E, et al. (2014) Effect of a tart cherry juice supplement on arterial stiffness and inflammation in healthy adults: a randomised controlled trial. Plant Foods Hum. Nutr. 69, 122-127.
85. Karlsen, A., Retterstøl, L., Laake, P., Paur, I., Kjølsrud-Bøhn, S., et al. (2007) Anthocyanins inhibit nuclear factor-κB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J. Nutr. 137, 1951-1954.
86. Busnelli, M., Froio, A., Bacci, M. L., Giunti, M., Cerrito, M. G., et al. (2009) Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs. Atherosclerosis 207, 384-390.
87. Stokes, K. Y., (2006) Microvascular responses to hypercholesterolemia: The interactions between innate and adaptive immune responses. Antioxid. Redox Signal. 8, 1141-1151.
88. Kolehmainen, M., Mykkänen, O., Kirjavainen, P. V., Leppänen, T., Moilanen, E., et al. (2012) Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Mol. Nutr. Food Res. 56, 1501-1510.
89. Karlsen, A., Paur, I., Bøhn, S. K., Sakhi, A. K., Borge, G. I., et al. (2010) Bilberry juice modulates plasma concentration of NF-κB related inflammatory markers in subjects at increased risk of CVD. Eur. J. Nutr. 49, 345-355.
90. Soltani, R., Hakimi, M., Asgary, S., Ghanadian, S. M., Keshvari, M., et al. (2014) Evaluation of the effects of Vaccinium arctostaphylos L. Fruit extract on serum lipids and hs-CRP levels and oxidative stress in adult patients with hyperlipidemia: a randomized, double-blind, placebo-controlled clinical trial. Evid.-Based Complement. Alternat. Med. 2014, 217451.
91. Riso, P., Klimis-Zacas, D., Del Bo, C., Martini, D., Campolo, J., et al. (2013) Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur. J. Nutr. 52, 949-961.
92. Wright, O. R., Netzel, G. A., and, Sakzewski, A. R., (2013) A randomized, double-blind, placebo-controlled trial of the effect of dried purple carrot on body mass, lipids, blood pressure, body composition, and inflammatory markers in overweight and obese adults: the QUENCH trial. Can. J. Physiol. Pharmacol. 91, 480-488.
93. Basu, A., Du, M., Leyva, M. J., Sanchez, K., Betts, N. M., et al. (2010) Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J. Nutr. 140, 1582-1587.
94. Ellis, C. L., Edirisinghe, I., Kappagoda, T., and, Burton-Freeman, B., (2011) Attenuation of meal-induced inflammatory and thrombotic responses in overweight men and women after 6-week daily strawberry (Fragaria) intake. A randomized placebo-controlled trial. J. Atheroscler. Thromb. 18, 318-327.
95. Stull, A. J., Cash, K. C., Johnson, W. D., Champagne, C. M., and, Cefalu, W. T., (2010) Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J. Nutr. 140, 1764-1768.
96. Asgary, S., Kelishadi, R., Rafieian-Kopaei, M., Najafi, S., Najafi, M., et al. (2013) Investigation of the lipid-modifying and antiinflammatory effects of Cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatr. Cardiol. 34, 1729-1735.
97. Asgary, S., Sahebkar, A, Afshani, M. R., Keshvari, M., Haghjooyjavanmard, S., et al. (2014) Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother. Res. 28, 193-199.
98. Zhu, Y., Ling, W., Guo, H., Song, F., Ye, Q., et al. (2013) Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial. Nutr. Metab. Cardiovasc. Dis. 23, 843-849.
99. Nile, S. H., and, Park, S. W., (2014) Edible berries: Bioactive components and their effect on human health. Nutrition 30, 134-144.
100. Benn, T., Kim, B., Park, Y. K., Wegner, C. J., Harness, E., et al. (2014) Polyphenol-rich blackcurrant extract prevents inflammation in diet-induced obese mice. J. Nutr. Biochem. 25, 1019-1025.
101. Vendrame, S., Daugherty, A., Kristo, A. S., Riso, P., and, Klimis-Zacas, D., (2013) Wild blueberry (Vaccinium angustifolium) consumption improves inflammatory status in the obese Zucker rat model of the metabolic syndrome. J. Nutr. Biochem. 24, 1508-1512.
102. Luo, H., Lv, X. D., Wang, G. E., Li, Y. F., Kurihara, H., et al. (2014) Anti-inflammatory effects of anthocyanins-rich extract from bilberry (Vaccinium myrtillus L.) on croton oil-induced ear edema and Propionibacterium acnes plus LPS-induced liver damage in mice. Int. J. Food Sci. Nutr. 65, 594-601.
103. Ou, T. T., Kuo, C. Y., Chyau, C. C., Lee, H. J., Peng, J. S., et al. (2013) Improvement of lipopolysaccharide-induced hepatic injuries and inflammation with mulberry extracts. J. Sci. Food Agric. 93, 1880-1886.
104. Tang, C. C., Huang, H. P., Lee, Y. J., Tang, Y. H., and, Wang, C. J., (2013) Hepatoprotective effect of mulberry water extracts on ethanol-induced liver injury via anti-inflammation and inhibition of lipogenesis in C57BL/6J mice. Food Chem. Toxicol. 62, 786-796.
105. Kaume, L., Gilbert, W. C., Brownmiller, C., Howard, L. R., and, Devareddy, L., (2012) Cyanidin 3-O-β- d -glucoside-rich blackberries modulate hepatic gene expression, and anti-obesity effects in ovariectomized rats. J. Funct. Foods 4, 480-488.
106. Peiffer, D. S., Zimmerman, N. P., Wang, L. S., Ransom, B. W., Carmella, S. G., et al. (2014) Chemoprevention of esophageal cancer with black raspberries, their component anthocyanins, and a major anthocyanin metabolite, protocatechuic acid. Cancer Prev. Res. (Phila.) 7, 574-584.
107. Zhu, W., Jia, Q., Wang, Y., Zhang, Y., and, Xia, M., (2012) The anthocyanin cyanidin-3-O-β-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: involvement of a cAMP-PKA-dependent signaling pathway. Free Radic. Biol. Med. 52, 314-327.
108. Decendit, A., Mamani-Matsuda, M., Aumont, V., Waffo-Teguo, P., Moynet, D., et al. (2013) Malvidin-3-O-β-glucoside, major grape anthocyanin, inhibits human macrophage-derived inflammatory mediators and decreases clinical scores in arthritic rats. Biochem. Pharmacol. 86, 1461-1467.
109. Del Cornò, M., Varano, B., Scazzocchio, B., Filesi, C., Masella, R., et al. (2014) Protocatechuic acid inhibits human dendritic cell functional activation: role of PPARγ up-modulation. Immunobiology 219, 416-424.
110. Hidalgo, M., Martin-Santamaria, S., Recio, I., Sanchez-Moreno, C., De Pascual-Teresa, B., et al. (2012) Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes Nutr. 7, 295-306.
111. Kropat, C., Mueller, D., Boettler, U., Zimmermann, K., Heiss, E. H., et al. (2013) Modulation of Nrf2-dependent gene transcription by bilberry anthocyanins in vivo. Mol. Nutr. Food Res. 57, 545-550.
112. Wang, D., Zou, T., Yang, Y., Yan, X., and, Ling, W., (2011) Cyanidin-3-O-β-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice. Biochem. Pharmacol. 82, 713-719.
113. Taverniti, V., Fracassetti, D., Del Bo, C., Lanti, C., Minuzzo, M., et al. (2014). Immunomodulatory effect of a wild blueberry anthocyanin-rich extract in human Caco-2 intestinal cells. J. Agric. Food Chem. 62, 8346-8351.
114. Hassellund, S. S., Flaa, A., Kjeldsen, S. E., Seljeflot, I., Karlsen, A., et al. (2013) Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study. J. Hum. Hypertens., 27, 100-106.
115. Dohadwala, M. M., Holbrook, M., Hamburg, N. M., Shenouda, S. M., Chung, W. B., et al. (2011) Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am. J. Clin. Nutr. 93, 934-940.